TianYu Bio-Technology Past Earnings Performance
Past criteria checks 0/6
TianYu Bio-Technology's earnings have been declining at an average annual rate of -58.7%, while the Commercial Services industry saw earnings growing at 4.7% annually. Revenues have been declining at an average rate of 0.3% per year.
Key information
-58.7%
Earnings growth rate
-58.0%
EPS growth rate
Commercial Services Industry Growth | 7.0% |
Revenue growth rate | -0.3% |
Return on equity | -58.4% |
Net Margin | -63.3% |
Next Earnings Update | 31 Aug 2024 |
Revenue & Expenses Breakdown
How TianYu Bio-Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 693 | -438 | 97 | 12 |
31 Dec 23 | 670 | -494 | 99 | 14 |
30 Sep 23 | 893 | -428 | 319 | 23 |
30 Jun 23 | 1,029 | -393 | 319 | 23 |
31 Mar 23 | 1,010 | -349 | 316 | 27 |
31 Dec 22 | 945 | -279 | 321 | 26 |
30 Sep 22 | 839 | -120 | 229 | 18 |
30 Jun 22 | 679 | -155 | 239 | 18 |
31 Mar 22 | 623 | -197 | 281 | 10 |
31 Dec 21 | 638 | -215 | 269 | 10 |
30 Sep 21 | 585 | -202 | 152 | 11 |
30 Jun 21 | 663 | -176 | 139 | 12 |
31 Mar 21 | 634 | -145 | 112 | 13 |
31 Dec 20 | 583 | -157 | 131 | 13 |
30 Sep 20 | 663 | 5 | 138 | 17 |
30 Jun 20 | 631 | 9 | 164 | 21 |
31 Mar 20 | 754 | 53 | 151 | 21 |
31 Dec 19 | 837 | 61 | 152 | 26 |
30 Sep 19 | 900 | 77 | 166 | 26 |
30 Jun 19 | 904 | 80 | 132 | 26 |
31 Mar 19 | 1,059 | 97 | 153 | 27 |
31 Dec 18 | 1,048 | 92 | 150 | 27 |
30 Sep 18 | 1,176 | 126 | 152 | 24 |
30 Jun 18 | 1,139 | 127 | 143 | 28 |
31 Mar 18 | 902 | 93 | 124 | 23 |
31 Dec 17 | 947 | 121 | 113 | 15 |
30 Sep 17 | 887 | 129 | 86 | 11 |
30 Jun 17 | 850 | 124 | 84 | 0 |
31 Mar 17 | 983 | 168 | 80 | 0 |
31 Dec 16 | 826 | 110 | 80 | 0 |
30 Sep 16 | 723 | 74 | 69 | 0 |
30 Jun 16 | 862 | 114 | 83 | 0 |
31 Mar 16 | 708 | 59 | 74 | 0 |
31 Dec 15 | 820 | 98 | 72 | 0 |
31 Dec 14 | 756 | 92 | 69 | 0 |
31 Dec 13 | 705 | 64 | 61 | 0 |
Quality Earnings: 603717 is currently unprofitable.
Growing Profit Margin: 603717 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 603717 is unprofitable, and losses have increased over the past 5 years at a rate of 58.7% per year.
Accelerating Growth: Unable to compare 603717's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 603717 is unprofitable, making it difficult to compare its past year earnings growth to the Commercial Services industry (-5.2%).
Return on Equity
High ROE: 603717 has a negative Return on Equity (-58.45%), as it is currently unprofitable.